Okuno M, Nakanishi T, Shinomura Y, Kiyohara T, Ishikawa H, Tarui S
2nd Department of Internal Medicine, Osaka University Medical School, Japan.
Experientia. 1992 Jan 15;48(1):47-50. doi: 10.1007/BF01923605.
Peptide YY (PYY) is thought to possess paracrine and endocrine functions. The highest concentrations of this peptide are in the colonic mucosa. The effect of PYY on electrolyte and water transport in the rat colon was studied in vivo. Under urethane anesthesia, rat colonic loops were perfused at a constant rate with physiological buffer solution containing phenol red as a nonabsorbable volume marker, and net movements of water, sodium, chloride and potassium in the perfused colon were determined every 10 min. Intravenous administration of PYY produced a dose-dependent increase in the net absorption of sodium chloride and water, as well as a decrease in the net secretion of potassium. PYY inhibited the reduction in net absorption of sodium chloride and water evoked by vasoactive intestinal peptide (VIP), but did not affect the VIP-evoked increase in net potassium secretion. These findings suggest that PYY acts as an enhancer of sodium chloride and water absorption and as an antagonist to VIP-induced secretion in the colon.
肽YY(PYY)被认为具有旁分泌和内分泌功能。这种肽的最高浓度存在于结肠黏膜中。在体内研究了PYY对大鼠结肠电解质和水转运的影响。在氨基甲酸乙酯麻醉下,用含有酚红作为不可吸收体积标记物的生理缓冲溶液以恒定速率灌注大鼠结肠肠袢,每10分钟测定灌注结肠中水分、钠、氯和钾的净移动。静脉注射PYY导致氯化钠和水的净吸收呈剂量依赖性增加,以及钾的净分泌减少。PYY抑制血管活性肠肽(VIP)引起的氯化钠和水净吸收的降低,但不影响VIP引起的钾净分泌增加。这些发现表明,PYY在结肠中作为氯化钠和水吸收的增强剂以及VIP诱导分泌的拮抗剂发挥作用。